https://immuno-spot.com/stop-tb-partnership-sounds-the-alarm-on-tuberculosis-funding-crisis/2022-10-29T14:41:46+00:00https://immuno-spot.com/apogenixs-asunercept-demonstrates-efficacy-in-covid-19-trial/2022-10-29T14:47:34+00:00https://immuno-spot.com/qic-diabetes-awards-2022-celebrate-uk-healthcare-excellence/2022-10-29T14:52:16+00:00https://immuno-spot.com/exelixis-announces-results-from-trial-evaluating-xb002/2022-10-30T08:31:25+00:00https://immuno-spot.com/positive-in-vitro-results-for-imutexs-flu-v/2022-10-30T08:36:09+00:00https://immuno-spot.com/canserv-rolls-out-cancer-research-services-across-europe/2022-10-30T08:40:14+00:00